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Osteoarthritis (OA) may result from intrinsic inﬂammation related to metabolic disturbance. Obesity-
associated inﬂammation is triggered by lipopolysaccharide (LPS) derived from the gut microbiota.
However, the relationship between gut microbiota, LPS, inﬂammation, and OA remain unclear.
Objective: To evaluate the associations between gut microbiota, systemic LPS levels, serum and local
inﬂammatory proﬁles, and joint damage in a high fat/high sucrose diet induced obese rat model.
Methods: 32 rats were randomized to a high fat/high sucrose diet (diet-induced obese (DIO), 40% fat, 45%
sucrose, n ¼ 21) or chow diet group (12% fat, 3.7% sucrose n ¼ 11) for 28 weeks. After a 12-week obesity
induction period, DIO animals were stratiﬁed into Obesity Prone (DIO-P, top 33% by change in body mass,
n ¼ 7), and Obesity Resistant groups (DIO-R, bottom 33%, n ¼ 7). At sacriﬁce, joints were scored using a
Modiﬁed Mankin Criteria. Blood and synovial ﬂuid analytes, serum LPS, and fecal gut microbiota were
analyzed.
Results: DIO animals had greater Modiﬁed Mankin scores than chow animals (P ¼ 0.002). There was a
signiﬁcant relationship (r ¼ 0.604, p ¼ 0.001) between body fat, but not body mass, and Modiﬁed Mankin
score. Eighteen synovial ﬂuid and four serum analytes were increased in DIO animals. DIO serum LPS
levels were increased compared to chow (P ¼ 0.031). Together, Lactobacillus species (spp.) and Meth-
anobrevibacter spp. abundance had a strong predictive relationship with Modiﬁed Mankin Score
(r2 ¼ 0.5, P < 0.001).
Conclusions: Increased OA in DIO animals is associated with greater body fat, not body mass. The link
between gut microbiota and adiposity-derived inﬂammation and metabolic OA warrants further
investigation.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Western-type diets, high in fat and sugars, lead to obesity1.
Obesity in turn is associated with chronic inﬂammation, and
thought to be a risk factor for the onset and increased rate of pro-
gression of metabolic osteoarthritis (OA) in joints2. Emerging evi-
dence suggests that intrinsic inﬂammatory mediators secreted byW. Herzog, 2500 University
Fax: 1-403-220-2070.
llins), haskochy@ucalgary.ca
rseerattan@kin.ucalgary.ca
og@ucalgary.ca (W. Herzog).
ternational. Published by Elsevier Lbody fat, or adipose tissue, including cytokines, adipokines, and
advanced glycation end products, may be sufﬁcient to lead to onset
and progression of OA3,4. It appears that these obesity-associated,
intrinsic inﬂammatory factors deﬁne a metabolic subtype of
OA5e7. Characterizing the factors that comprise this unhealthy
metabolic phenotype is critical to understanding the inﬂuence of
obesity on OA. Furthermore, establishing the “indirect” role of the
microbiota and the gut is required to fully understand the initiators
and drivers of metabolic OA.
Experimental high fat diets (45e60% of energy derived from
lard-based fat rich in saturated fatty acids) have been associated
with an increase in OA independent of gains in body weight8e11.
However, these diets do not accurately represent the typical humantd. All rights reserved.
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fat) would be considered extreme. Rather, the obesity epidemic in
North America appears driven by processed foods high in fat and
simple carbohydrates, which is better modeled by a high fat/high
sucrose (HFS) diet12.
When fed a HFS diet, SpragueeDawley rats, as well as Wistar
rats and C57BL/6C mice, exhibit obesity prone (top ~50% of weight
gainers) and obesity resistant (bottom ~50% of weight gainers)
phenotypes, where obesity resistant animals grow normally and
the prone become obese13. This feature allows for experimental
evaluationwherein animals are all exposed to the same obesogenic
diet but develop disparate body weight13. However, the effect of
HFS diet-induced obesity on OA in prone and resistant animals has
yet to be experimentally evaluated.
Although the extent to which inﬂammatory mediators
contribute to metabolic OA remains unknown, several cytokines
and adipokines detected in serum and synovial ﬂuid of obese ani-
mals have been implicated8,10,11,14e17. In particular, leptin is elevated
in serum and synovial ﬂuid of obese individuals and animals with
OA18. However, the detailed molecular origins of such low-grade
systemic inﬂammation remain unknown19. Systemically, visceral
adipocytes, macrophages, and adipose tissue mast cells have been
suggested to contribute to this chronic inﬂammatory state20. In
knee joints, the infrapatellar fat pad and synovial ﬂuid are thought
to contribute to the local inﬂammatory environment21e23.
Recently, a link between low-grade inﬂammation and changes
in the composition and activity of the microbes that reside in the
gastrointestinal tract, collectively termed the gut microbiota, has
been established. Notably, high fat diets enhance translocation of
the bacterial membrane component lipopolysaccharide (LPS) into
the bloodstream, initiating obesity and insulin resistance24. New
evidence suggests that the gut microbiota, through activating
innate immune responses that lead to systemic inﬂammation,
represent a possible mechanistic link to metabolically induced
OA25. As metabolic OA may be one manifestation of a systemic
metabolic disorder, our objective is to evaluate gut microbiota
changes induced by a HFS diet in the context of OA. Speciﬁcally, we
want to identify potential associations between gut microbial
proﬁles, serum and synovial ﬂuid cytokine and adipokine proﬁles,
and knee joint damage.
We hypothesize that HFS diet-induced obesity, regardless of
weight gain, will result in increased Modiﬁed Mankin Scores when
compared with chow-fed control animals. Furthermore, we explore
the associations between gut microbiota, systemic LPS levels,
serum and local inﬂammatory proﬁles, and joint damage in HFS
animals in order to better understand the development of Meta-
bolic OA.
Method
Animals
Thirty-two male, 8e12-week old SpragueeDawley rats, housed
individually on a 12 h dark/light cycle, were purchased from a
speciﬁc pathogen free facility (Charles River Laboratories) and
maintained at the University of Calgary with standard monitoring
thereafter. Animals were allocated to the HFS diet-induced obesity
group (diet-induced obese (DIO), 40% of total energy from fat, 45%
of total energy from sucrose, n ¼ 21, Diet #102412, Dyets, Inc), or
the standard control chow diet group (12% fat, 3.7% sucrose n ¼ 11,
Lab Diet 5001) for a 28-week ad libitum feeding intervention26. The
HFS diet consisted of (g/100 g): casein (20.0), sucrose (49.9), soy-
bean oil (10.0), lard (10.0), Alphacel (5.0), AIN-93M mineral mix
(3.5), AIN- 93 vitamin mix (1.0), DL-methionine (0.3), and choline
bitartrate (0.25). The energy densities of the HFS and chow dietswere 4.60 kcal/g and 3.34 kcal/g respectively. All experiments were
approved by the University of Calgary Life and Environmental Sci-
ences Animal Care Committee. After a 12-week obesity induction
period, DIO animals were stratiﬁed into tertiles according to
changes in body mass, resulting in an Obesity Prone group (DIO-P,
top 33% of animals by change in body mass, n ¼ 7), an Obesity
Resistant group (DIO-R, bottom 33% of animals by change in body
mass, n ¼ 7), and a middle tertile group, which is not further
considered here.
Body composition
Animals were followed for 28 weeks (36e40 weeks old), at
which point they were euthanized by barbiturate overdose
(Euthanyl®, MTC Animal Health Inc., Cambridge, Ontario, Canada).
Immediately after sacriﬁce, body composition was measured using
Dual Energy X-ray Absorptiometry with software for small animal
analysis (Hologic QDR 4500; Hologic, Bedford, MA).
Preparation of knee joints
Joints were harvested by cutting the femur and tibia/ﬁbula 2 cm
above and below the joint line. Decalciﬁcation and processing of
the joints was conducted according to previously described
methods7. Serial, sagittal plane sections of 8 mm thickness were
obtained using a Leica RM 2165 rotary microtome. Sections were
mounted on Super Frost plus slides (Fisher Scientiﬁc) and allowed
to dry at 40C for 4 days. Sampling was done approximately every
80 mm, thus alternate slides were stained sequentially with hae-
matoxylin, fast green and safranin-O stains (Fisher Scientiﬁc) using
an auto stainer (Leica ST 5010). Sections were then dehydrated in a
graded series of alcohols, cleared in xylene, and mounted with
cytoseal 60 mounting media (Richard Allan) using an auto cover
slipper (Leica CV 5030). Slides were dried at room temperature for
several days before being evaluated using a light microscope (Zeiss
Axiostar plus, Carl Zeiss Inc., Toronto, Ontario, Canada). Images
were digitized using a Zeiss Axiocam® Icc 5 camera and analyzed
using the Zen 2011 Zeiss imaging system. Sections were examined
under 10 and 25 objectives and scored for OA degeneration
using a Modiﬁed Mankin scoring system27.
OA scoring
A Modiﬁed Mankin Score was used to describe the volumetric
damage in each joint. Five areas were evaluated: the medial and
lateral tibial plateau, the medial and lateral femoral condyle, and
the patella. These ﬁve sites were assigned a score based on the
standard 14-point Mankin scale27. Subchondral bone and synovium
were then assessed using a 5 and 4 point criteria, respectively, that
was adapted from the rat-speciﬁc OARSI metric28. Meniscal damage
was scored on a scale of 0e5. The ﬁnal Modiﬁed Mankin score was
obtained by adding the ﬁve site-speciﬁc Mankin scores, the two
corresponding OARSI scores, and the meniscal damage score27e29.
The inter-rater reliability between two independent assessors was
r > 0.95.
Cytokine, growth factor, adipokine and LPS measurements
Animals were sacriﬁced following a 12 h fast, and blood was
collected immediately via cardiac puncture. Serum was stored
at 80C until analysis. Synovial ﬂuid was collected shortly after
sacriﬁce using the Whatman chromatography paper method30.
Samples were weighed, diluted 1:30, centrifuged at 13,500 rpm,
and stored at 20C overnight. Samples were aliquoted 24 h later
and stored at 80C until analysis.
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kines were quantiﬁed using a Rat 27 Multiplex Discovery Assay
with Luminex®xMAP technology (Eotaxin, EGF, Fractalkine, IL-1a,
IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12(p70), IL-13, IL-17A, IL-18, IP-
10/CXCL10, GRO/KC, IFN-g, TNF-a, G-CSF, GM-CSF, MCP-1, leptin,
LIX, MIP-1a, MIP-2, RANTES, VEGF; Eve Technologies, Calgary, AB).
Synovial ﬂuid from the left and right limbs of each animal was
pooled for quantiﬁcation. Urea was evaluated in duplicate in serum
and synovial ﬂuid using ELISA (Sigma Aldrich Urea Kit, Eve Tech-
nologies, Calgary, AB) while accounting for volumetric differences
in synovial ﬂuid concentration31. Systemic LPS was evaluated using
EndoZyme Recombinant Factor C Assay (Hyglos GmbH, Germany).
Gut microbiota proﬁling using qPCR
Microbial proﬁling of 12 microbial groups (total bacteria, Bacter-
oides/Prevotella species (spp.), Clostridium coccoides (cluster XIV),
Clostridium leptum (cluster IV), Clostridium clusters XI and I, Roseburia
spp., Lactobacillus spp., Biﬁdobacterium spp.,Methanobrevibacter spp.,
Enterobacteriaceae, Akkermansia muciniphila) was performed ac-
cording to our previous work and microbial abundance was
measured as the number of 16S rRNA gene copies per 20 ng total
genomic DNA (primers provided in Supplementary Table 1)32,33.
Brieﬂy, total microbial DNA was extracted from fecal samples using
the FastDNA Spin Kit for Feces (MP Biomedicals, Lachine, QC, Canada)
and quantiﬁed using PicoGreen DNA quantiﬁcation kit (Invitrogen,
Carlsbad, CA, USA). Samples were then diluted to 4 ng/ml and stored
at20C until analysis. Ampliﬁcation and detectionwere conducted
in 96-well plates with SYBR Green 2  qPCR Master Mix (BioRad).
Samples were assessed in duplicate with a ﬁnal volume of 25 ml
containing 0.3 mM primer and 20 ng template genomic DNA. The
speciﬁcity of the primers and the limit of detectionwere determined
according to previously reported methods34. Puriﬁed template DNA
from reference strains was used to generate standard curves for each
primer set using serial dilutions of DNA. Standard curves were
normalized to copy number of 16S rRNA genes (ng genomic DNA
converted into genome copies according to calculations outlined in
the followingwebpage http://cels.uri.edu/gsc/cndna.html and values
for 16S rRNA gene copies/genome obtained from the following
database http://rrndb.mmg.msu.edu).
Statistical analysis
Right knee joints from all 32 animals were scored and analyzed.
Blood, synovial ﬂuid, and feces were collected from all 14 DIO an-
imals and 6 chow animals. Levene's test for equality of variancewas
conducted on all outcomes. If signiﬁcant (P < 0.05), KruskaleWallis
non-parametric tests were used to evaluate between phenotype/
diet groups (DIO-P, DIO-R, Chow), and between strictly dietary
groups (all DIO, Chow). Differences in Modiﬁed Mankin scores,
synovial ﬂuid analytes, sera analytes, fecal microbes, and LPS were
evaluated. If equal variances were found, ANOVAs were performed
to assess differences between groups. Bonferronni corrections were
utilized to control for multiple testing error. Multiple linear
regression equations were used to evaluate each analyte with body
fat to predict Modiﬁed Mankin Scores. Pearson correlations and
multiple linear regression equations were used to associate Modi-
ﬁed Mankin scores with gut microbes, synovial ﬂuid inﬂammatory
markers, and serum inﬂammatory markers by diet using IBM SPSS
Statistics 20 (a ¼ 0.05).
Results
DIO-P rats were heavier than both DIO-R and chow-fed controls
by week nine of the obesity induction period and remained heavierthrough the remainder of the study [P ¼ 0.03, Fig. 1(a)]. At sacriﬁce,
DIO-R and chow-fed controls had similar mass [P ¼ 0.25, Fig. 1(b)],
but DIO-P and DIO-R animals had increased body fat compared to
control group animals [P < 0.001, Fig. 1(c)].
Joint scores
DIO group animals had greater Modiﬁed Mankin scores than
chow-fed control animals [P¼ 0.002, Fig. 1(d)]. Therewas a positive
relationship (r ¼ 0.60, P ¼ 0.001) between body fat percentage and
Modiﬁed Mankin scores across all animals, but this relationship
was not signiﬁcant when each dietary group was evaluated inde-
pendently. No statistically signiﬁcant relationship was found be-
tween body mass and Modiﬁed Mankin scores. Despite having
more mass, DIO-P animals had similar Modiﬁed Mankin Scores to
the DIO-R group (P ¼ 0.81, Fig. 2). Of the categories summed to
create the total Modiﬁed Mankin Score, medial tibial plateau (MTP)
and groove scores were signiﬁcantly increased in DIO-P and DIO-R
compared to chow (P ¼ 0.013 and P ¼ 0.002, respectively, Table I).
Inﬂammatory markers
Nineteen synovial ﬂuid analytes were increased in DIO animals
compared with chow-fed control animals (Table II). There were no
detectable differences in synovial ﬂuid analytes between DIO-P and
DIO-R animals. Five serum analytes (leptin, IP-10, GRO-KC, MIP-2
and MIP-1a) were increased in DIO animals compared to chow-
fed control animals. These serum analytes were also signiﬁcantly
associated with increased synovial ﬂuid analytes in DIO animals
compared to chow-fed control animals (leptin: associated with 11/
18 increased synovial ﬂuid analytes; IP-10: 15/18; GRO-KC: 3/18;
MIP-1a: 6/18). Finally, synovial ﬂuid IL-1awas positively associated
with Modiﬁed Mankin Scores across all animals (r ¼ 0.48,
P ¼ 0.029). An association between Modiﬁed Mankin Score and
synovial ﬂuid IL-1b approached signiﬁcance (r ¼ 0.40, P ¼ 0.067).
Gut microbiota
The overall composition of gut microbes differed between DIO
and chow-fed control animals (Fig. 3). DIO animals demonstrated
an increased ratio of Firmicutes (sum total of C. coccoides, C. leptum,
Clostridium clusters XI and I, Roseburia spp., Lactobacillus spp.) to
Bacteroidetes (Bacteroides/Prevotella spp.) due to a lower abun-
dance of Bacteroides/Prevotella spp. (P ¼ 0.016), as the total abun-
dance of Firmicutes was similar between groups (all group data
shown in Supplementary Table 2). However, within the Firmicutes
phylum, the relative composition of microbiota differed between
DIO animals and chow-fed control animals, mainly within the
lactobacilli and clostridial bacterial groups (Fig. 3). Overall, the
proﬁle of Firmicutes in DIO-P and DIO-R animals was similar.
Serum LPS levels were higher in DIO animals (n ¼ 14) compared
to chow-fed control animals (n¼ 6, DIO 2.18 (2.13e2.23) log EU/mL,
chow 2.06 (1.91e2.20) log EU/mL, P ¼ 0.031). Furthermore, LPS
levels were increased in DIO-P animals compared with DIO-R (P:
2.24 (2.17e2.30) log EU/mL, R: 2.13 (2.07e2.18) EU/mL, P ¼ 0.008).
Relationships between Modiﬁed Mankin Scores, inﬂammation, and
microbiota
LPS concentration was associated with body fat (r ¼ 0.62,
P ¼ 0.003) and Lactobacillus spp. abundance (r ¼ 0.60, P ¼ 0.009).
Additionally, a signiﬁcant negative relationship between Lactoba-
cillus spp. abundance and Modiﬁed Mankin Score was found
(0.45, P ¼ 0.04, Supplementary Table 2). Despite no difference in
Methanobrevibacter spp. abundance between dietary groups, there
a b
c d
Fig. 1. Longitudinal body mass (a), ﬁnal body mass (b), percent body fat (c) and Modiﬁed Mankin Score (d) in diet-induced obesity prone (DIO-P) and resistant (DIO-R) rats and
chow-fed control rats. Data are presented as Mean and 95% CI for obesity prone (n ¼ 7), obesity resistant (n ¼ 7), and chow-fed control animals (n ¼ 11). In all panels, * denotes a
signiﬁcant difference (P < 0.05) between obesity prone vs obesity resistant and chow-fed control animals. # denotes a signiﬁcant difference (P < 0.05) with chow-fed control
animals.
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abundance and Modiﬁed Mankin Score (r ¼ 0.51, P ¼ 0.02,
Supplementary Table 2). Together, using linear regression, Meth-
anobrevibacter spp. and Lactobacillus spp. abundance had a strong
predictive relationship with Modiﬁed Mankin Scores (r2 ¼ 0.50,
P < 0.001, Fig. 4, Table III).
Both microbial groups demonstrated signiﬁcant relationships
with synovial ﬂuid and serum inﬂammatory mediators. Methano-
brevibacter spp. abundance had a signiﬁcant positive relationship
with synovial ﬂuid [IL-1b (r¼ 0.47, P¼ 0.03), LIX (r¼ 0.54, P¼ 0.01),
MIP-2 (r ¼ 0.47, P ¼ 0.03) and RANTES (r ¼ 0.44, P ¼ 0.04)], but was
not associated with any of the serum inﬂammatory mediators.
Lactobacillus spp. abundance was negatively associated with sy-
novial ﬂuid leptin (r ¼ 0.50, P ¼ 0.01), IL-12 (r ¼ 0.50, P ¼ 0.02),
IL-13 (r ¼ 0.48, P ¼ 0.029), IFN-g (r ¼ 0.57, P ¼ 0.008), MCP-1
(r ¼ 0.47, P ¼ 0.30), LIX (r ¼ 0.50, P ¼ 0.02), TNF-a (r ¼ 0.50,
P ¼ 0.04), serum leptin (r ¼ 0.46, P ¼ 0.04), and positively asso-
ciatedwith IL-4 (r¼ 0.50, P¼ 0.02), EGF (r¼ 0.57, P¼ 0.009), and IL-
17 (r ¼ 0.44, P ¼ 0.05).
Discussion
The aim of this study was to identify potential cross-sectional
associations between inﬂammation, gut microbiota and knee
joint damage in the context of HFS diet-induced obesity. Our pri-
mary ﬁnding was that DIO animals, independent of body weight,
had similar Mankin scores that were greater than those found in
chow-fed control animals. Since body fat was higher in DIO-P and
DIO-R animals compared to control group animals, while body
mass was the same for DIO-R and control group animals, it appearsthat body fat, rather than body mass, is a risk factor for joint
damage. Another key ﬁnding was the detection of a distinct in-
ﬂammatory signature in synovial ﬂuid and serum of DIO group
animals which was more pronounced in synovial ﬂuid. The abun-
dance of the gut microbes Lactobacillus spp. was negatively and
Methanobrevibacter spp. positively associated with Mankin Scores
and pro-inﬂammatory mediators in serum and synovial ﬂuid.
Finally, increased levels of serum LPS may provide a link between
the associations measured between gut microbes, chronic inﬂam-
mation and increased joint damage.
Mankin Scores were not signiﬁcantly related to total body mass;
a ﬁnding that has been reported previously9e11,14,35,36. Typically,
obesity-induced OA has been associated with increased joint
loading. However, we found that DIO-R animals had signiﬁcantly
higher Mankin Scores than chow-fed control animals despite
similar body weight. Moreover, DIO-P and DIO-R animals, which
both consumed the HFS diet, had similar Mankin scores, despite the
signiﬁcantly higher body weight in the DIO-P than DIO-R group
animals. Furthermore, we found a positive relationship between
body fat percentage andMankin scores, supporting the idea that OA
onset and progressionmay be affected by intrinsic factors related to
metabolic disturbance rather than joint loading, although more
detailed studies of how differences in body composition affect joint
loading are warranted10,37.
In order to understand the proﬁle of a diet-induced systemic
inﬂammatory environment, blood serum was assessed for 27 cy-
tokines, growth factors, and hormones. Five serum analytes asso-
ciated with adipose inﬂammationwere increased in all DIO animals
compared to chow-fed control group animals38. Two of these, GRO-
KC and MIP-1a, have been linked to insulin resistance and are
Fig. 2. MTP Histological slides from one representative of an obesity prone (panel A;
MTP score ¼ 14, Total score ¼ 53), obesity resistant (panel B; MTP score ¼ 14, Total
score ¼ 47), and chow-fed control (panel C; MTP score ¼ 3, Total score ¼ 23) animal.
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K.H. Collins et al. / Osteoarthritis and Cartilage 23 (2015) 1989e1998 1993regulated via autocrine signaling by adiponectin, an adipocytokine
that is decreased in obesity39. Although not directly measured,
adiponectin may play a protective anti-inﬂammatory role in OA40.
The increase in serum GRO-KC and MIP-1a suggests that adipo-
nectin may be decreased in the serum of all DIO animals, but not
necessarily in the synovial ﬂuid. Our data suggest that factors
downstream of adiponectin, like GRO-KC and MIP-1a, may be po-
tential treatment targets in metabolic OA.
Leptin, a satiety hormone and key inﬂammatory mediator, has
been widely explored in humans and animals to explain the effect
of obesity on onset and progression of OA14,18. In contrast to others,
we did not ﬁnd a relationship between OA severity and serum
levels of leptin; however, leptin and a mediator selectively acti-
vated by leptin, IP-10, were increased in the serum of DIO ani-
mals18. Given that visceral adipose tissue, which secretes
inﬂammatory mediators more actively than subcutaneous adipose
tissue, is associated with hand OA in men, there is the possibility
that adipose-derived factors inﬂuence the joint environment
Table II
Synovial ﬂuid and serum inﬂammatory markers in (DIO) and chow control-diet fed control rats. P < 0.05 is indicated by*, data are presented as mean and 95% CI of the mean
Analyte DIO [synovial ﬂuid] ng/mL
n ¼ 14
CHOW [synovial ﬂuid]
n ¼ 6
P-value DIO [serum] ng/mL
n ¼ 14
CHOW [serum]
n ¼ 6
P-value
Mean (CI) Mean (CI) Mean (CI) Mean (CI)
EGF 0.74 (0.18e1.10) 0.13 (0.06e0.20) 0.024* 0.02 (0e0.2) 0.01 (0e0.15) 0.265
Eotaxin 0.73 (0.46e1.0) 0.30 (0.10e0.30) 0.043* 0.01 (0e0.1) 0.01 (00.1) 0.458
Fractalkine 9.45 (6.16e12.74) 3.69 (1.76e5.62) 0.023* 0.05 (0.04e0.06) 0.05 (0.04e0.06) 0.869
GRO-KC 5.53 (1.16e7.81) 2.62 (1.11e4.13) 0.043* 0.15 (0.09e0.21) 0.05 (0.02e0.09) 0.032*
IFN-g 19.87 (2.08e23.95) 8.43 (1.66e11.7) 0.013* 0.10 (0.06e0.13) 0.13 (0.07e0.20) 0.215
IL-10 1.81 (1.75e3.57) 0.28 (0.07e0.42) 0.050* 0.10 (0.08e0.13) 0.09 (0.06e0.12) 0.680
IL-12 2.66 (1.75e3.57) 0.83 (0.21e1.44) 0.050* 0.19 (0.15e0.24) 0.23 (0.16e0.29) 0.343
IL-13 2.23 (1.65e2.81) 1.04 (0.34e1.74) 0.031* 0.03 (0.03e0.04) 0.04 (0.03e0.05) 0.483
IL-17a 0.39 (0.22e0.57) 0.11 (0.04e0.19) 0.261 0.02 (0.01e0.03) 0.03 (0.02e0.05) 0.322
IL-18 1054.72 (830.4e1279.04) 626.86 (331.44e922.29) 0.050* 0.18 (0.13e0.24) 0.21 (0.10e0.31) 0.869
IL-1a 31.28 (16.5e46.05) 11.44 (1.30e21.58) 0.020* 0.01 (0.01e0.02) 0.02 (0.01e0.02) 0.679
IL-1b 95.31 (54.09e136.53) 34.04 (16.66e51.42) 0.117 0.04 (0.02e0.06) 0.04 (0.02e0.06) 0.710
IL-2 2.52 (1.44e3.59) 0.74 (0.10e1.39) 0.035* 0.12 (0.10e0.15) 0.15 (0.08e0.23) 0.592
IL-6 25.98 (18.58e33.39) 9.92 (5.35e14.20) 0.050* 0.39 (0.16e0.62) 0.50 (0.07e0.93) 0.591
IP-10 7.84 (3.98e11.69) 2.16 (1.15e3.17) 0.007* 0.33 (0.27e0.39) 0.22 (0.17e0.26) 0.017*
Leptin 1698.76 (1309.2e2088.33) 397.44 (205.14e589.74) 0.022* 44.62 (33.93e55.30) 20.02 (15.83e24.22) 0.017*
LIX 15.01 (10.86e19.17) 5.76 (1.28e10.24) 0.045* 4.82 (3.32e6.32) 3.87 (2.20e5.53) 0.509
MCP-1 39.98 (22.09e57.88) 4.09 (1.68e6.50) 0.002* 1.83 (1.52e2.13) 1.42 (1.28e1.56) 0.117
MIP-2 0.93 (0.24e1.61) 0.77 (0e2.17) 0.869* 0.04 (0.03e0.05) 0.02 (0.01e0.03) 0.043*
MIP-1a 1.07 (0.77e1.37) 0.51 (0.3e0.71) 0.789 0.02(0.02e0.03) 0.01 (0.01e0.02) 0.043*
RANTES 7.57 (3.93e1.86) 2.31 (1.60e3.20) 0.013* 1.61 (1.03e2.18) 0.72 (0.44e0.99) 0.099
TNF-a 0.25 (0.17e0.33) 0.09 (0.02e0.17) 0.003* 0.02 (0.01e0.02) 0.02 (0.02e0.01 0.620
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fat pad and bone41.
The synovial ﬂuid cytokine, growth factor, and hormone proﬁles
in DIO animals were distinct from chow-fed control animals.
Despite a higher body fat percentage in DIO-P compared with DIO-
R group animals, there were no signiﬁcant differences in the 27
synovial analytes measured here, indicating similar inﬂammatory
environments in the knee. This result implies that a HFS diet isFig. 3. Relative microbial abundance of 16S rRNA gene copies per 20 ng fecal DNA from
chow-fed control (n ¼ 6), diet-induced obesity (n ¼ 14), obesity prone (n ¼ 7) and
obesity resistant (n ¼ 7) animals.sufﬁcient to modify the knee inﬂammatory environment, a ﬁnding
that may be explained partly by an altered gut microbial proﬁle. Of
the nineteen inﬂammatory markers increased in DIO synovial ﬂuid,
IL-1a was the only analyte that had a signiﬁcant positive relation-
ship with the Mankin scores. IL-1a and IL-1b are considered gate-
keepers of inﬂammation, and have been implicated in early OA
changes42. Leptin, in conjunction with IL-1a and TNF-a, has been
shown to directly induce cartilage damage23. Furthermore, the
infrapatellar fat pad can be a signiﬁcant contributor of leptin levels
in knees, and leptin may be critical to disturbing homeostasis in
joints when present in sufﬁciently high concentrations15,23. Serum
and synovial ﬂuid leptin levels were increased in DIO animals, in
agreement with reported ﬁndings15. Despite similar synovial ﬂuid
levels of IL-1b in DIO and chow animals, the positive association
between IL-1b and OAwas approaching signiﬁcance in this dataset.
Time-course data may clarify the respective roles of IL-1a and IL-1b
in this model.Fig. 4. Predicted Modiﬁed Mankin Score based on abundance of Lactobacillus spp. and
Methanobrevibacter spp. plotted against the measured Modiﬁed Mankin Score for DIO
(n ¼ 14) and LFD (n ¼ 6), r2 ¼ 0.50.
Table III
Summary of outputs from linear regression modeling estimating Modiﬁed Mankin Scores across all obese (DIO, n ¼ 14) and chow (n ¼ 6) animals. b-coefﬁcients and predicted
Modiﬁed Mankin Scores for each model are presented as mean and 95% CI of the mean. R-squared (r2), F-statistics, standard error of the estimate, and P-value of the model are
also provided
Factors included r2 b F-statistic Standard error
of estimate
P-value
of model
Predicted modiﬁed Mankin score
Model Factor 1 Factor 2 Mean CI lower
limit
CI upper
limit
Mean CI lower
limit
CI upper
limit
A Methanobrevibacter spp. Lactobacillus spp. 0.50 30.3 17.6 41.7 7.7 9.8 0.04 46.2 40.9 51.5
B Methanobrevibacter spp. Body Fat Percentage 0.37 12.7 10.3 35.7 5.3 10.6 0.16 46.2 40.9 51.5
C Methanobrevibacter spp. Leptin SF 0.34 23.2 6.3 40.0 3.0 10.8 0.02 46.2 40.1 51.2
D Lactobacillus spp. Body Fat Percentage 0.21 44.1 11.7 76.5 2.3 11.9 0.13 46.2 40.9 51.1
E Lactobacillus spp. Leptin Serum 0.27 57.2 42.9 71.5 3.2 11.2 0.67 45.4 40.0 50.6
F Leptin Serum Leptin SF 0.17 44.1 31.9 56.3 1.7 11.9 0.20 45.4 39.9 50.6
G Body fat percentage Leptin SF 0.16 32.9 8.4 57.4 1.7 12.3 0.20 46.2 40.1 51.7
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by many tissues and pathways, obesity's impact in the local envi-
ronment may differ across tissues and joints. Concordant with
previous reports, increases in the magnitude of local inﬂammatory
markers in synovial ﬂuid compared to serum were observed15.
Moreover, all of the increased serum inﬂammatory markers in our
DIO animals were positively associated with at least three synovial
ﬂuid inﬂammatory markers suggesting an effect of systemic
inﬂammation on the joint.
In order to further understand factors affecting the peripheral
inﬂammatory environment, gut microbiota composition was
assessed. Gut microbiota composition and activity, especially in
individuals consuming a Western-type diet, has been linked with
the rising incidence of metabolic disease, including obesity and
type 2 diabetes1. Consistent with evidence that obesity in animal
models is generally associatedwith an increase in Firmicutes with a
concomitant decrease in Bacteroidetes, we found that DIO animals
exhibited an increased Firmicutes:Bacteroidetes ratio43.
Furthermore, Lactobacillus spp. and Methanobrevibacter spp.
abundance may directly or indirectly explain a moderate amount of
the Mankin Score. Although a strong predictive association be-
tween these microbes and Mankin Score was demonstrated, this
relationship warrants further investigation to elucidate linkages
with local and systemic inﬂammatory marker concentrations. To
provide context of this relationship, the predictive strength of
leptin levels in the serum and synovial ﬂuid were calculated, as
leptin has been identiﬁed as a marker strongly associated with
OA18. Although the conﬁdence intervals (CIs) for predictive values
were similar from both models, the standard error of estimate
achieved from the model using Methanobrevibacter spp. and
Lactobacillus spp. was lower. This data indicates that these micro-
bial groups could be examined further, as they are similar in pre-
dictive power to leptin in both ﬂuids.
Though not consistent across all strains, certain lactobacilli have
been associated with health-promoting properties, including
attenuated weight gain, reduced recruitment of inﬂammatory
macrophages in adipose tissue, and improved gut barrier func-
tion44,45. Furthermore, reduced lactobacilli abundance has been
reported in animals consuming diets high in saturated fat46. Here,
the higher levels of plasma LPS in DIO group animals suggest that
HFS-fed animals have increased gut permeability, which may be
due in part to observed decreases in lactobacilli abundance.
Importantly, oral administration of Lactobacillus casei in an exper-
imental rat model of OA led to reduced inﬂammation and cartilage
degradation and has been suggested as a possible treatment for
Metabolic OA47. Animal studies have also linked Methano-
brevibacter spp. abundancewith increased weight gain and adipose
tissue growth48. Surprisingly, despite the positive relationship be-
tween Methanobrevibacter spp. abundance and Mankin Scores,
Methanobrevibacter spp. abundance was not different betweendietary groups. However, the overall pattern of gut microbial
composition can impact hostemicrobial interactions49. Hence, the
combination of decreased lactobacilli and the potential obesity-
associated effects of Methanobrevibacter spp. may partly explain
the association of Methanobrevibacter spp. with Mankin Scores
despite the lack of statistical difference in abundance.
There are several limitations to this work. As designed our study
is not able to establish causality. However, with this dataset,
mechanistic considerations between the contributions of the gut
microbiota or changes in diet in OA development can be
approached with more understanding. Factors such as mobility and
joint loading have not been examined here, as kinetic data are
difﬁcult to collect and interpret given the marked increase in
abdominal adiposity in our DIO animals. Lastly, the middle tertile of
DIO animals were not considered here. Future studies should
carefully address the interaction of obesity and joint loading in
determining the contributions of metabolic and mechanical factors
to knee OA. Moreover, future considerations of the spectrum of DIO
animals could be used to assess the potential threshold and/or the
linear relationship between body fat and Metabolic OA.
The goal of this work was to evaluate systemic inﬂuences of
diet-induced obesity on the knee joint inﬂammatory environment.
We show that body fat, not body mass, is associated with OA
damage in the knee, and that a distinct inﬂammatory serum and
synovial ﬂuid signature differentiates obese and chow-fed control
animals. The source of this inﬂammation remains to be clariﬁed.
We propose that a potential link between body fat inﬂammation,
microbiota, and OA damage may be increased translocation of
bacterial LPS into the bloodstream (Fig. 5). LPS-induced inﬂam-
mation in adipose tissue could precipitate systemic changes in
cytokines, adipokines, and growth factors, including leptin, IP-10
and IL-1a, that ultimately contribute to OA development by
affecting the local inﬂammatory environment inside the knee50.
Whether circulating LPS directly impacts the secretion of inﬂam-
matory cytokines from cells of the infrapatellar fat pad remains to
be examined. Future work evaluating inﬂammatory markers in
serum and synovial ﬂuid over time, in conjunction with measuring
inﬂammatory marker gene expression in the infrapatellar fat pad,
synovium and fat depots from various locations, will help deter-
mine the potential sources of the inﬂammationmeasured here. The
present series of experiments suggest that systemic factors beyond
what has currently been shown or proposed, including the gut
microbiota, may play a role in metabolic OA and warrant further
investigation.
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